Arcus Biosciences, Inc. RCUS

24.97 (0.09) (0.36%) as of 25 Sep
Market cap
$3.2B
P/E
0.0×

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Cash and Short Term Investments
981.00 978.00 759.00 1,009.00 499.00 728.65 188.27 256.54 175.70 98.90
Receivables
11.00 20.00 38.00 39.00 745.00 1.70 0.38 0.08 0.03 0.41
Total current assets
1,007.00 1,016.00 831.00 1,067.00 1,262.00 735.82 192.71 258.95 176.87 99.69
Property, Plant, Equpment (Net)
40.00 47.00 51.00 35.00 32.00 10.81 9.33 11.11 11.23 8.61
Long-Term Investments
29.00 14.00 107.00 129.00 182.00 6.44 0.00 4.38 0.68 1.20
Goodwill and Intangible Assets (Total)
— — — — — — — — — 0.00
Long-term assets (Other)
63.00 73.00 106.00 114.00 116.00 6.45 1.08 0.49 1.71 0.20
Total non-current assets
132.00 134.00 264.00 278.00 330.00 36.48 10.41 15.98 13.62 —
Total Assets
1,139.00 1,150.00 1,095.00 1,345.00 1,592.00 772.29 203.11 274.93 190.49 0.00
Accounts Payable
42.00 18.00 17.00 20.00 10.00 15.68 4.70 3.10 3.82 3.87
Accrued Expenses
— — — — 53.77 27.85 9.52 6.02 3.14 —
Current Part of Capital Lease
— — — — — — — — — 0.00
Current Part of Taxes to Pay
— — — — — — — — — 0.00
Current Revenue (Deferred)
35.00 85.00 91.00 97.00 102.00 74.57 7.00 6.25 5.00 —
Other current liabilities
154.00 123.00 76.00 76.00 54.00 3.57 1.48 1.56 0.77 1.68
Total current liabilities
231.00 226.00 184.00 193.00 166.00 121.67 22.71 16.94 12.73 5.55
Long Term Debt (Total)
99.00 48.00 — 117.00 117.00 15.00 — — — —
Non-current Revenue (Deferred)
43.00 234.00 307.00 355.00 462.00 132.53 12.02 16.98 18.59 0.00
Minority Interests
— — — — — — — — — 0.00
Non-current Liabilities (Other)
135.00 157.00 142.00 140.00 122.00 0.54 4.54 6.06 5.31 4.70
Total non-current liabilities
277.00 439.00 449.00 495.00 584.00 148.32 16.56 23.05 23.89 —
Total liabilities
508.00 665.00 633.00 688.00 750.00 269.99 39.27 39.98 36.62 0.00
Additional Paid In Capital
— — — — 1,118.06 830.44 369.10 357.87 0.95 0.00
Preferred Stock (Total)
— — — — — — — — 226.20 0.00
Common Stock (Net)
2,116.00 1,617.00 1,311.00 1,206.00 1,118.00 0.01 0.00 0.00 0.00 0.00
Retained Earnings
(1,485.00) (1,132.00) (849.00) (542.00) (275.00) (328.18) (205.33) (122.83) (73.23) (20.15)
Treasury Stock
— — — — — — — — — 0.00
Shareholders Equity (Other)
— — — — — — — — — 0.00
Common Equity (Total)
631.00 485.00 462.00 657.00 842.00 502.30 163.84 234.94 (72.33) (19.99)
Shareholders Equity (Total)
631.00 485.00 462.00 657.00 842.00 502.30 163.84 234.94 153.87 0.00
Shareholders Equity and Liabilities (Total)
1,139.00 1,150.00 1,095.00 1,345.00 1,592.00 772.29 203.11 274.93 190.49 0.00
Shares (Common)
125.30 92.20 75.50 72.90 70.80 63.69 45.93 44.54 4.09 —
Shares (Preferred)
— — — — — — — — 30.46 —
Shareholders Equity (Tangible)
631.00 485.00 462.00 657.00 842.00 502.30 163.84 234.94 153.87 —
Net Debt
(882.00) (930.00) (759.00) (892.00) (382.00) (713.65) (188.27) (256.54) (175.70) (98.90)
Total Debt
99.00 48.00 — 117.00 117.00 15.00 — — — —

Fold the line items

In millions of $ except per-share values · columns are period end dates